- Home
- PSHG vs HOOK Comparison
PSHG vs HOOK Comparison
Compare PSHG & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSHG
- HOOK
- Stock Information
- Founded
- PSHG 2010
- HOOK 2011
- Country
- PSHG Greece
- HOOK United States
- Employees
- PSHG N/A
- HOOK N/A
- Industry
- PSHG Marine Transportation
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- PSHG Consumer Discretionary
- HOOK Health Care
- Exchange
- PSHG Nasdaq
- HOOK Nasdaq
- Market Cap
- PSHG 20.1M
- HOOK 18.1M
- IPO Year
- PSHG N/A
- HOOK 2019
- Fundamental
- Price
- PSHG $1.37
- HOOK $0.80
- Analyst Decision
- PSHG Strong Buy
- HOOK Buy
- Analyst Count
- PSHG 1
- HOOK 4
- Target Price
- PSHG $6.50
- HOOK $10.67
- AVG Volume (30 Days)
- PSHG 45.6K
- HOOK 39.5K
- Earning Date
- PSHG 05-29-2025
- HOOK 05-08-2025
- Dividend Yield
- PSHG N/A
- HOOK N/A
- EPS Growth
- PSHG N/A
- HOOK N/A
- EPS
- PSHG 1.12
- HOOK N/A
- Revenue
- PSHG $87,445,000.00
- HOOK $43,946,000.00
- Revenue This Year
- PSHG N/A
- HOOK N/A
- Revenue Next Year
- PSHG $31.45
- HOOK N/A
- P/E Ratio
- PSHG $1.22
- HOOK N/A
- Revenue Growth
- PSHG N/A
- HOOK 118.32
- 52 Week Low
- PSHG $1.31
- HOOK $0.72
- 52 Week High
- PSHG $2.58
- HOOK $10.50
- Technical
- Relative Strength Index (RSI)
- PSHG 37.20
- HOOK 30.29
- Support Level
- PSHG $1.34
- HOOK $0.73
- Resistance Level
- PSHG $1.55
- HOOK $0.85
- Average True Range (ATR)
- PSHG 0.08
- HOOK 0.08
- MACD
- PSHG -0.00
- HOOK 0.02
- Stochastic Oscillator
- PSHG 20.83
- HOOK 35.39
About PSHG Performance Shipping Inc.
Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates eight Aframax tanker vessels.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.